Product Description
Olaparib Pharma tablets, acclaimed for their praiseworthy efficacy, are film-coated tablets designed for targeted oncology therapy. Each tablet contains 150 mg of Olaparib, an inestimable PARP enzyme inhibitor, offering maintenance treatment for adults with BRCA-mutated advanced ovarian, fallopian tube, or primary peritoneal cancer. The product comes in a secure aluminum-PVC blister pack, typically with 56 tablets per box, maximizing savings and convenience for both patients and healthcare providers. Redeem the best of pharmaceutical innovation with this prescription-only treatment, delivered under strict medical supervision.
Advantage & Application Areas of Olaparib Pharma Tablets
Olaparib Pharma tablets are administered orally, providing high bioavailability at the site of action. The best advantage lies in their ability to offer targeted cancer therapy, specifically for BRCA-mutated ovarian, fallopian tube, or primary peritoneal cancer. Used in maintenance therapy, these tablets deliver praiseworthy results due to their PARP enzyme inhibition, thus advancing oncology applications and supporting patients throughout treatment.
Certifications, Shipment and Export Markets
Olaparib Pharma tablets are delivered promptly, with shipment managed to ensure medicines reach their destination securely. Shipped goods adhere to strict pharmaceutical certifications and quality standards. Mainly exported from India, these tablets reach international markets focused on oncology needs. Each shipment is timely and handled under conditions that protect quality, providing assurance for exporters, suppliers, and traders serving global healthcare communities.
FAQ's of olaparib Pharma tablets:
Q: How should Olaparib Pharma tablets be stored for optimal efficacy?
A: Olaparib Pharma tablets should be stored below 30C and protected from moisture. This helps maintain their shelf life and ensures the tablets remain effective up to 24 months from the date of manufacture.
Q: What is the primary indication for using Olaparib Pharma tablets?
A: These tablets are primarily indicated for the maintenance treatment of adult patients with BRCA-mutated advanced ovarian, fallopian tube, or primary peritoneal cancer, under medical supervision.
Q: When should Olaparib Pharma tablets not be used?
A: Olaparib Pharma tablets are not recommended during pregnancy or lactation due to potential risks. They must be taken only as prescribed, under the guidance of a healthcare professional.
Q: Where can I obtain Olaparib Pharma tablets?
A: Olaparib Pharma tablets are available only by prescription through licensed healthcare providers, pharmacies, or authorized exporters and suppliers in India and international markets.
Q: What is the process for exporting and shipping Olaparib Pharma tablets?
A: Export and shipment of Olaparib Pharma tablets follow pharmaceutical protocols, ensuring goods are certified and delivered safely. Shipped goods are packed securely in aluminum-PVC blister packs and dispatched to major international markets.
Q: How does Olaparib Pharma benefit patients with BRCA-mutated cancers?
A: Olaparib Pharma provides targeted PARP enzyme inhibition, which supports maintenance treatment in patients with BRCA-mutated ovarian, fallopian tube, or primary peritoneal cancer, often leading to improved outcomes in advanced oncology cases.